RxDoctor Payments Data

Damian Illing, MD

Orthopaedic Surgery · Ogden, UTNPI 1437536554

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (39.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Arthrex at 58.4% of the total. Reporting peaked in 2020 at $10,703 and has fallen 97.1% since, to $309 in 2025.

$25,333in general payments, 2019–2025

Across 114 payments — averaging $222.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$15K
  • Active Medical, LLC$2K
  • Skeletal Dynamics Inc$2K
  • Axogen$2K
  • Acumed LLC$1K
  • Gemini Mountain Medical, LLC$703
  • plus $2K from 21 others

What the payments were for

  • Grants$10,00039%
  • Travel & lodging$5,31221%
  • Food & beverage$3,31813%
  • Education$6,70326%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,333 in reported general payments places this provider in the 75th percentile of 221 orthopaedic surgery providers in Utah.

See all orthopaedic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$71,524
Medicare patients
109
Services billed
718

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl58$140

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Ogden

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →